[Skip to Content]
[Skip to Content Landing]
Views 465
Citations 0
Viewpoint
October 2018

Assessing the Credibility of Findings From Nonrandomized Studies of Interventions

Author Affiliations
  • 1Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
  • 2National Institute for Health Research Bristol Biomedical Research Centre, University of Bristol, Bristol, United Kingdom
JAMA Cardiol. 2018;3(10):905-906. doi:10.1001/jamacardio.2018.2267

Randomized clinical trials (RCTs) are widely accepted as the gold standard in the assessment of health interventions. However, evidence from RCTs is often unavailable. Randomized clinical trials may also be impractical, for example when the outcome of interest is so rare or so long term that appropriately sized studies would be too expensive. In addition, RCTs require clinical equipoise, and withholding established treatments may be considered unethical even if evidence for the effects of these treatments is limited. Finally, RCTs may be underway but not ready for reporting for some years.

×